aspirin primari prevent angina pectori random trial unit physician purpos object studi effect low-dos aspirin mg altern day primari prevent angina pectori unit health studi postul role platelet atherogenesi myocardi ischemia effect chronic platelet inhibit develop clinic angina pectori unknown subject method health studi random double-blind placebo-control trial male physician year free previou myocardi infarct stroke transient cerebr ischemia entri averag month physician free angina pectori baselin studi popul present analys result person-year follow-up patient confirm angina pectori coronari revascular procedur coronari arteri bypass graft surgeri coronari angioplasti particip placebo rel risk confirm angina pectori aspirin group confid interv CI coronari revascular rel risk CI simultan control coronari risk factor proportional-hazard model rel risk uniti CI CI risk angina pectori year random trial pattern benefit durat treatment conclus trial data chronic platelet inhibit low-dos aspirin averag durat month incid angina pectori 